Let's look at two examples investors should consider: Novavax (NASDAQ: NVAX) and Netflix (NASDAQ: NFLX). Can a company that isn't yet profitable be considered "cheap?" In my view, the answer is yes, and Novavax is a good example. Although there is still red on the bottom line, the biotech is generating revenue from its coronavirus vaccine, Nuvaxovid. Read More...
Let’s look at two examples investors should consider: Novavax (NASDAQ: NVAX) and Netflix (NASDAQ: NFLX). Can a company that isn’t yet profitable be considered “cheap?” In my view, the answer is yes, and Novavax is a good example. Although there is still red on the bottom line, the biotech is generating revenue from its coronavirus vaccine, Nuvaxovid.
